business

Daiichi Sankyo halts trials of existing drug for COVID-19 treatment

3 Comments

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© Thomson Reuters 2021.

©2021 GPlusMedia Inc.

3 Comments
Login to comment

I wonder what happened. I just did a quick search on this drug and found it has actually been used before so we might see wider use anyway

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332736/

https://clinicaltrials.gov/ct2/show/NCT04418128

https://www.clinicaltrialsarena.com/news/sun-pharma-nafamostat-trial/

-1 ( +1 / -2 )

The company said in a statement it was discontinuing the trial without citing a reason. 

Which can be understood as not showing enough efficacy even at high doses close to what is considered the limits of safety. No real mystery. The same is what is likely happening with the Anges vaccine.

2 ( +4 / -2 )

Happening to most existing drugs...

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites